KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Encompass Health (EHC) Other Non-Current Assets (2016 - 2025)

Encompass Health (EHC) has disclosed Other Non-Current Assets for 17 consecutive years, with $243.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 11.18% year-over-year to $243.7 million, compared with a TTM value of $243.7 million through Dec 2025, up 11.18%, and an annual FY2025 reading of $243.7 million, up 11.18% over the prior year.
  • Other Non-Current Assets was $243.7 million for Q4 2025 at Encompass Health, up from $209.5 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $274.4 million in Q1 2021 and bottomed at $178.7 million in Q1 2024.
  • Average Other Non-Current Assets over 5 years is $216.1 million, with a median of $219.2 million recorded in 2024.
  • The sharpest move saw Other Non-Current Assets tumbled 39.39% in 2021, then rose 24.22% in 2022.
  • Year by year, Other Non-Current Assets stood at $178.8 million in 2021, then rose by 24.22% to $222.1 million in 2022, then dropped by 13.73% to $191.6 million in 2023, then grew by 14.41% to $219.2 million in 2024, then increased by 11.18% to $243.7 million in 2025.
  • Business Quant data shows Other Non-Current Assets for EHC at $243.7 million in Q4 2025, $209.5 million in Q1 2025, and $219.2 million in Q4 2024.